<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="severe or with complications were considered [5]. In the Netherlands," exact="oseltamivir" post="was the drug of first choice for treatment of"/>
 <result pre="risk patients suspected of influenza during the pandemic. Treatment with" exact="zanamivir" post="was reserved for patients suspected for an infection with"/>
 <result pre="this study was therefore to investigate whether the prescription of" exact="oseltamivir" post="by general practitioners (GPs) in the Netherlands was in"/>
 <result pre="national database to estimate 1) the proportion of patients receiving" exact="oseltamivir" post="according to the guidelines in relation to patients’ and"/>
 <result pre="and 2) what proportion of patients diagnosed with influenza received" exact="oseltamivir" post="and which factors determined this prescription. Methods Practices and"/>
 <result pre="the GPs were considered. First, patients having a prescription of" exact="oseltamivir" post="(ATC-code J05AH02) between August 8 and December 31, 2009"/>
 <result pre="8 and December 31, 2009 were considered. No prescriptions of" exact="zanamivir" post="were registered. When there was more than one oseltamivir"/>
 <result pre="of zanamivir were registered. When there was more than one" exact="oseltamivir" post="prescription, only the first one was taken into account."/>
 <result pre="to take into account registration delays. However, in 88% of" exact="oseltamivir" post="prescriptions, the diagnosis was registered at the same day."/>
 <result pre="illness outside the influenza season). Patients who did not receive" exact="oseltamivir" post="were evaluated for a diagnosis of influenza. When more"/>
 <result pre="consultation was taken. Recommended treatment of high risk patients with" exact="oseltamivir" post="was based on age (&amp;lt;2 years or ≥60 years),"/>
 <result pre="– within these days), or a third trimester pregnancy (an" exact="oseltamivir" post="prescription or an influenza diagnosis between 20 to 34"/>
 <result pre="child had to be no more than 14 weeks after" exact="oseltamivir" post="prescription or influenza diagnosis). Details on ICPC- and ATC-codes"/>
 <result pre="we evaluated the proportion of patients whom had been prescribed" exact="oseltamivir" post="and whom should have been prescribed it. Univariate logistic"/>
 <result pre="analyses were performed on the association between the prescription of" exact="oseltamivir" post="and a recommendation for a prescription, as well as"/>
 <result pre="associated with the prescription of oseltamivir. Likewise, we evaluated whether" exact="oseltamivir" post="was prescribed according to the guidelines among all patients"/>
 <result pre="all patients receiving oseltamivir. Because of the recommendation to prescribe" exact="oseltamivir" post="to both very young (under two years of age)"/>
 <result pre="enlisted patients) had been prescribed oseltamivir. The total number of" exact="oseltamivir" post="prescriptions ranged between practices from 0 (11 practices) to"/>
 <result pre="geometric mean = 0.9; geometric standard distribution = 3.4). Half of the patients receiving" exact="oseltamivir" post="had a diagnosis of influenza (n = 181; 51.6%). The most"/>
 <result pre="valid ICPC-code was recorded for 23 patients (6.6%). Of all" exact="oseltamivir" post="prescriptions, 241 (68.7%) were to patients belonging to the"/>
 <result pre="shows the distribution of the underlying reasons for qualification for" exact="oseltamivir" post="in these patients. Table 1 Characteristics of 241 patients"/>
 <result pre="at high risk of severe illness who had been prescribed" exact="oseltamivir" post="n of patients (%) High risk group description  Age"/>
 <result pre="age were associated with an increased chance of having an" exact="oseltamivir" post="prescription according to the recommendations. Independently of age, a"/>
 <result pre="number of prescriptions in general were positively associated with prescribing" exact="oseltamivir" post="according to the guidelines. Table 2 Factors influencing a"/>
 <result pre="to the guidelines. Table 2 Factors influencing a prescription of" exact="oseltamivir" post="according to clinical guidelines in 351 patients with antiviral"/>
 <result pre="to 6.42) 0.001 GP = general practitioner; OR = odds ratio; CI = confidence interval. *Excluding" exact="oseltamivir" post="prescriptions. A total of 3,293 patients (1.3% of the"/>
 <result pre="(1.3% of the study population) were diagnosed with influenza and" exact="oseltamivir" post="was prescribed to 181 (5.5%). The weekly number of"/>
 <result pre="of prescriptions in 2009 were determinants of the prescription of" exact="oseltamivir" post="among influenza patients (Table 3). Patients with underlying co-morbidity"/>
 <result pre="Patients with underlying co-morbidity had the highest chance of an" exact="oseltamivir" post="prescription. All of the designated high risk groups were"/>
 <result pre="the designated high risk groups were statistically significantly associated with" exact="oseltamivir" post="prescription, except children receiving chronic aspirin therapy. Taking into"/>
 <result pre="complicated course of illness, but this was not associated with" exact="oseltamivir" post="treatment. Practice characteristics were not associated with oseltamivir prescriptions."/>
 <result pre="associated with oseltamivir treatment. Practice characteristics were not associated with" exact="oseltamivir" post="prescriptions. Table 3 Potential factors influencing the prescription of"/>
 <result pre="oseltamivir prescriptions. Table 3 Potential factors influencing the prescription of" exact="oseltamivir" post="by general practitioners to 3,293 influenza patients Prescription of"/>
 <result pre="interval. *Reference group does not have the specific co-morbidity. †Excluding" exact="oseltamivir" post="prescriptions. The results of the multilevel model with age,"/>
 <result pre="60 years or above in itself was not associated with" exact="oseltamivir" post="prescription. Independently of a high risk for severe disease"/>
 <result pre="at high risk of severe illness were not associated with" exact="oseltamivir" post="prescription, nor were age, gender, and consultation rate or"/>
 <result pre="or practice characteristics (Table 4). The only significant determinant for" exact="oseltamivir" post="prescriptions was the total number of drug prescriptions in"/>
 <result pre="to 4.32). Table 4 Potential factors influencing the prescription of" exact="oseltamivir" post="to 2,242 influenza patients not at high risk Prescription"/>
 <result pre="(0.40 to 1.82) GP = general practitioner; OR = odds ratio; CI = confidence interval. *Excluding" exact="oseltamivir" post="prescriptions. Discussion This study showed that general practitioners in"/>
 <result pre="general practitioners in the Netherlands have been restrained in prescribing" exact="oseltamivir" post="during the influenza pandemic. Only 5% of all patients"/>
 <result pre="can be considered proxies for underlying morbidity, were determinants for" exact="oseltamivir" post="prescription in addition to the high risk factors of"/>
 <result pre="[14], who found that 85% of Dutch patients with an" exact="oseltamivir" post="prescription belonged to the high risk groups. Their study"/>
 <result pre="on telephone interviews with patients who filled a prescription for" exact="oseltamivir" post="through community pharmacists. Results from other countries on prescriptions"/>
 <result pre="through community pharmacists. Results from other countries on prescriptions of" exact="oseltamivir" post="during the A(H1N1)pdm09 pandemic are scarce. In a study"/>
 <result pre="Chicago hospital, 65% of high-risk patients with influenza-like illness received" exact="oseltamivir" post="treatment [17]. These figures are much higher than in"/>
 <result pre="our study. The results of our study show that if" exact="oseltamivir" post="was prescribed, it was in accordance with the guidelines"/>
 <result pre="fairly well. But they often did not prescribe, even when" exact="oseltamivir" post="was recommended. The availability of antiviral drugs was no"/>
 <result pre="available from the national stockpile. A possible explanation for withholding" exact="oseltamivir" post="to patients at higher risk of complications might have"/>
 <result pre="this is the first study in which recommendations for prescribing" exact="oseltamivir" post="in primary care has been evaluated in detail. More"/>
 <result pre="rate more so than practice featuresPrev Med20023540140610.1006/pmed.2002.108312453719 FietjéEHPhilbertDvan GeffenECWintersNABouvyMLAdherence to" exact="oseltamivir" post="guidelines during influenza pandemic, the NetherlandsEmerg Infect Dis20121853453510.3201/eid1803.11135122377063 HershALStaffordRSAntiviral"/>
</results>
